2 in 5 COVID-19 survivors have a new disability, study finds
In a recent study published in Critical Care, researchers found six months after recovering from COVID-19 critical illness, one in five people had died, and...
Scientists find more effective COVID-19 treatment
In a new study from the University of Colorado, researchers examined a key aspect of the immune system during COVID-19: the interferon response.
They found...
Milk may help fighting COVID-19, study finds
As the COVID-19 pandemic continues to claim lives around the world, dairy scientists may have a surprising role to play.
In a new study from...
Scientists find durable immunity against COVID-19 variants
In a new study from Oregon Health & Science University, researchers found the blood of people infected by COVID-19 showed telltale signals of immunity...
Bark of neem tree may protect against COVID-19 variants
In a new study from the University of Colorado and elsewhere, researchers found an extract from the bark of the neem tree may help...
Two at-home COVID-19 treatments are available
This week, the FDA authorized two oral antivirals for the treatment of COVID-19 in certain patients.
The first is Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged...
Scientists discover a novel vaccine method to prevent COVID-19 infection
In a new study from The University of Hong Kong, researchers found an effective vaccine regimen in preventing SARS-CoV-2 nasal infection.
They found that a...
Johnson COVID-19 vaccine 85% effective against Omicron
In a new study from the South African Medical Research Council, researchers found a homologous (same vaccine) booster shot of the Johnson & Johnson...
COVID-19 can trigger self-attacking antibodies even in mild cases
In a new study from Cedars-Sinai, researchers found infection with the virus that causes COVID-19 can trigger an immune response that lasts well beyond...
Three days of this drug cuts risk for severe COVID-19
In a new study from the Baylor University Medical Center, researchers found a three-day course of remdesivir results in a lower risk for hospitalization...